Search results for abx831390
Showing 1 – 10 of1products
ID: BAB041562324
Rozanolixizumab, Abbexa, abx831390
Rozanolixizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting FCGRT, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Rozanolixizumab is under investigation in clinical trial NCT03861481 (A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy).
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Request a product
Please provide the required information below so that we can quickly source your products.